CytomX Therapeutics CTMX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CytomX Therapeutics's intangibles (net)?
- CytomX Therapeutics (CTMX) reported intangibles (net) of $401K in Q1 2026.
- How has CytomX Therapeutics's intangibles (net) changed year-over-year?
- CytomX Therapeutics's intangibles (net) decreased by 26.7% year-over-year, from $547K to $401K.
- What is the long-term trend for CytomX Therapeutics's intangibles (net)?
- Over 5 years (2020 to 2025), CytomX Therapeutics's intangibles (net) has grown at a -17.8% compound annual growth rate (CAGR), from $1.17M to $438K.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.